Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,438 | 181,724 | 187,750 | 11,357 | 126,310 |
| Marketable Securities | 262,887 | 105,113 | 59,622 | N/A | 140,129 |
| Receivables | 1,091 | 10,061 | 262 | N/A | 12,037 |
| TOTAL | $385,592 | $300,639 | $254,081 | $12,531 | $282,976 |
| Non-Current Assets | |||||
| PPE Net | 16,908 | 18,935 | 20,626 | 1,311 | 29,157 |
| Investments And Advances | 52,260 | 117,620 | 3,000 | 0 | 11,434 |
| Intangibles | 60,954 | 62,676 | 89,432 | 0 | 33,469 |
| Other Non-Current Assets | 58,370 | 63,933 | 61,863 | 1,880 | 468 |
| TOTAL | $188,492 | $263,164 | $174,921 | $3,191 | $74,528 |
| Total Assets | $574,084 | $563,803 | $429,002 | $15,722 | $357,504 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,751 | 8,580 | 3,995 | 939 | 1,457 |
| Accrued Expenses | 33,636 | 17,104 | 15,674 | 1,250 | 13,060 |
| Other current liabilities | 2,500 | 10,000 | N/A | N/A | N/A |
| TOTAL | $50,835 | $40,085 | $22,809 | $2,427 | $30,517 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 95 | N/A | 16,000 |
| Other Non-Current Liabilities | 76,232 | 69,340 | 55,194 | 54,300 | 1,838 |
| TOTAL | $81,308 | $70,075 | $71,571 | $54,414 | $191,676 |
| Total Liabilities | $132,143 | $110,160 | $94,380 | $56,841 | $222,193 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,846 | 54,951 | 42,377 | 16,151 | 15,942 |
| Common Shares | 7 | 5 | 4 | N/A | 8 |
| Retained earnings | -419,631 | -231,766 | -128,829 | -47,207 | -404,532 |
| Other shareholders' equity | -3,164 | -55 | 11 | -7 | 940 |
| TOTAL | $441,941 | $453,643 | $334,622 | $-41,119 | $135,311 |
| Total Liabilities And Equity | $574,084 | $563,803 | $429,002 | $15,722 | $357,504 |